Letter to the Editor From Fitzpatrick et al: “Zoledronate After Denosumab Discontinuation: Is Repeated Administrations More Effective Than A Single Infusion?”-Reference-Cited by-同舟云学术

Letter to the Editor From Fitzpatrick et al: “Zoledronate After Denosumab Discontinuation: Is Repeated Administrations More Effective Than A Single Infusion?”

Published:2024-07-15 Issue: Volume: Page:
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Fitzpatrick Donal¹²^ORCID,Lannon Rosaleen¹²,McCarroll Kevin¹²

Affiliation:

1. Bone Health Unit, Mercer's Institute for Successful Ageing, St James's Hospital , Dublin D08 NHY1 , Ireland

2. School of Medicine, Trinity College Dublin , Dublin D02 R590 , Ireland

Publisher

The Endocrine Society

Link

https://academic.oup.com/jcem/advance-article-pdf/doi/10.1210/clinem/dgae491/58631686/dgae491.pdf

Reference6 articles.

1. Zoledronate after denosumab discontinuation: is repeated administrations more effective than single infusion?;Grassi;J Clin Endocrinol Metab

2. Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS;Tsourdi;J Clin Endocrinol Metab,2021

3. Treatment with zoledronate subsequent to denosumab in osteoporosis: a randomized trial;Sølling;J Bone Miner Res,2020

4. The duration of denosumab treatment and the efficacy of zoledronate to preserve bone mineral density after its discontinuation;Makras;J Clin Endocrinol Metab,2021

5. Relationship between bone mineral density T-score and nonvertebral fracture risk over 10 years of denosumab treatment;Ferrari;J Bone Miner Res,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to: Letter to the Editor From Fitzpatrick et al: “Zoledronate After Denosumab Discontinuation: Is Repeated Administrations More Effective Than Single Infusion?”;The Journal of Clinical Endocrinology & Metabolism;2024-07-15